Skip to Main Content

Paper Details

Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.
Anaerobe
1
2023
C. difficile, COVID, Clostridioides difficile, PROCLAIM, misoprostol, participants
COVID-19, Clostridioides, Clostridioides difficile, Clostridium Infections, Feasibility Studies, Humans, Misoprostol
Author NameAffiliation
Robert R LavieriThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Erik R DubberkeWashington University School of Medicine in St. Louis
Sarah K McGillUniversity of North Carolina School of Medicine
Luther A BarteltUniversity of North Carolina School of Medicine
Stephanie A SmithThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Balint K PandurThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Sharon PhillipsVanderbilt University Medical Center
Krista K VermillionThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Jana K Shirey-RiceThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Jill M PulleyThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Yaomin XuVanderbilt University Medical Center
Christopher J LindsellThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Nicole M ZaleskiThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Rebecca N JeromeThe Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt University Medical Center
Ryan S DosterUniversity of Louisville School of Medicine
David M AronoffIndiana University School of Medicine
  • 1 - 16

Datasets